Jasper Therapeutics Files Q1 2025 10-Q
Ticker: JSPRW · Form: 10-Q · Filed: May 12, 2025 · CIK: 1788028
| Field | Detail |
|---|---|
| Company | Jasper Therapeutics, Inc. (JSPRW) |
| Form Type | 10-Q |
| Filed Date | May 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, biotech
TL;DR
Jasper Therapeutics (JSPR) filed its Q1 2025 10-Q. All systems go.
AI Summary
Jasper Therapeutics, Inc. filed its 10-Q for the quarterly period ended March 31, 2025. The company, formerly known as Amplitude Healthcare Acquisition Corp, is incorporated in Delaware and operates in the biological products sector. Its principal executive offices are located in Redwood City, California.
Why It Matters
This filing provides investors with the latest financial and operational updates for Jasper Therapeutics, Inc. for the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial and business information.
Key Players & Entities
- Jasper Therapeutics, Inc. (company) — Registrant
- March 31, 2025 (date) — Quarterly period end date
- Amplitude Healthcare Acquisition Corp (company) — Former company name
- 2200 Bridge Pkwy Suite #102 (address) — Principal executive offices
- Redwood City, CA (location) — City and State of principal executive offices
- 001-39138 (identifier) — Commission File Number
FAQ
What is the reporting period for this 10-Q filing?
The 10-Q filing is for the quarterly period ended March 31, 2025.
What is the company's full legal name as specified in its charter?
The company's full legal name is Jasper Therapeutics, Inc.
In which state was Jasper Therapeutics, Inc. incorporated?
Jasper Therapeutics, Inc. was incorporated in Delaware.
What is the business address of Jasper Therapeutics, Inc.?
The business address is 2200 Bridge Pkwy Suite #102, Redwood City, CA 94065.
What was the former name of Jasper Therapeutics, Inc.?
The former company name was Amplitude Healthcare Acquisition Corp.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 12, 2025 regarding Jasper Therapeutics, Inc. (JSPRW).